Creative Biosciences (Guangzhou) Co., Ltd.
PrivateLast Round
Series D
Oct 20, 2021
Total Funding Raised
$223.52M
Company Overview
Creative Biosciences (Guangzhou) Co., Ltd. operates in Healthcare & Life Sciences and is based in Guangzhou. Its latest recorded funding round was a Series D round in October 2021.
Creative Biosciences (Guangzhou) Co., Ltd. is a biotechnology company that specializes in the development and manufacturing of non-invasive cancer detection kits and point-of-care testing (POCT) products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Creative Biosciences (Guangzhou) Co., Ltd. Comparables
Compare Creative Biosciences (Guangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wuhan Ammunition Life-tech Co., Ltd. | 85% | |
| New Horizon Health | 83% | |
| Shanghai Realbio Technology Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Creative Biosciences (Guangzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 20, 2021 | ||||
| Series C | Sep 27, 2020 | ||||
| Strategic | Aug 1, 2019 | ||||
| Series B | Apr 12, 2019 | ||||
| VC Round | Jun 1, 2016 | ||||
Pre Seed | Jul 1, 2015 |
For institutional investors. Book with your work email.
Creative Biosciences (Guangzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Linden Asset | Series C |
| IDG Capital | Series D, Series B, Series C |
| Agricultural Bank of China International | Series D |
| Bohai Industrial Investment Fund Management Co., Ltd. | Series A |
| 健壹资本 | Strategic |
| Oceanpine Capital | Series C |
| Guangzhou Financial Holdings Fund Management | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2020
$88M round with participation from CDH Investments and IDG Capital.
- Apr 12, 2019
$45M round with CDH Investments, CD Capital, and IDG Capital.
For institutional investors. Book with your work email.
Creative Biosciences (Guangzhou) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Creative Biosciences (Guangzhou) Co., Ltd.'s valuation, stock price, and market status.
Is Creative Biosciences (Guangzhou) Co., Ltd. a public or private company?
Creative Biosciences (Guangzhou) Co., Ltd. is a private company.
What is the current stock price of Creative Biosciences (Guangzhou) Co., Ltd.?
Creative Biosciences (Guangzhou) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Creative Biosciences (Guangzhou) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Creative Biosciences (Guangzhou) Co., Ltd. worth (valuation)?
Valuation information for Creative Biosciences (Guangzhou) Co., Ltd. is not publicly available.
Can I buy Creative Biosciences (Guangzhou) Co., Ltd. stock?
Creative Biosciences (Guangzhou) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Creative Biosciences (Guangzhou) Co., Ltd.'s last funding round?
Creative Biosciences (Guangzhou) Co., Ltd.'s most recent funding round was Series D on October 20, 2021.
Who are the main investors in Creative Biosciences (Guangzhou) Co., Ltd.?
Key investors in Creative Biosciences (Guangzhou) Co., Ltd. include YuanBio Venture Capital.
Will Creative Biosciences (Guangzhou) Co., Ltd. IPO soon?
No public IPO plans have been announced for Creative Biosciences (Guangzhou) Co., Ltd..
How can I track Creative Biosciences (Guangzhou) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Creative Biosciences (Guangzhou) Co., Ltd.'s shares on secondary markets.